Orexo's digital therapy deprexis® reimbursed under the US Veterans Affairs Federal Supply Schedule
· Orexo is granted a Veterans Affairs Federal Supply Schedule contract for deprexis® in the US and will be reimbursed and made available by the federal government for use within the Veterans Affairs Health System, Indian Health Service and Department of Defence effective late July 2022 · This long-term contract provides product access to close to 15 million US citizens who receive healthcare through the federal government · Deprexis® will be made available to patients as Orexo secures access through healthcare providers with an expected start late Q4 2022 Uppsala, Sweden – July 13,